We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Peptide Mix Makes HIV Self-Destruct in a Petri Dish

By LabMedica International staff writers
Posted on 07 Sep 2010
A new study describes a peptide cocktail that causes apoptotic cell death of HIV infected cells, with total extermination of the virus.

Researchers at the Hebrew University (Jerusalem, Israel) developed a novel approach to eradicate HIV-1 infected cells specifically and significantly, as well as to eliminate infectious virions from cultured cells. More...
The process involves the stimulation of viral integrase (IN) enzymatic activity by the IN derived-integrase stimulatory (INS) peptide and IN derived-Rev interacting (INrs) peptides to disrupt the IN complex, combined with the prevention of virion production by the protease inhibitor Ro 31-8959.

The researchers found a correlation between increase in the integration of HIV-1 cDNA and cell death, showing that the combination of peptides that stimulate integration, together with the protease inhibitor caused apoptotic cell death of the HIV infected cells. This combination did not have any effect on noninfected cells, appearing to promote cell death only in infected cells. The researchers suggest that the results could provide a novel approach to promote the death of HIV-1 infected cells specifically, and may eventually be developed into a new and general antiviral therapy. The study was published on august 19, 2010, in Aids Research and Therapy, a publication of Biomed Central.

"Whilst this research is promising, a major caveat with these studies is that they are preliminary,” said lead author Abraham Loyter, Ph.D., of the department of biological chemistry. "So far these experiments have only been shown to 'cure' HIV from small dishes of cultured cells in the authors' laboratory, but the findings are an exciting development in the quest to eradicate this devastating global pandemic.”

A virion consists of a complete virus particle, composed of nucleic acid surrounded by a protective coat of protein called a capsid; these are formed from identical protein subunits called capsomers. One of the problems with battling HIV is that it evades the immune system by constantly changing the amino acid sequence of the proteins on the surface of the virion.

Since most viruses cannot be seen with a light microscope, scanning and transmission electron microscopes are used to visualize the virion.

Related Links:

Hebrew University



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.